Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
McKinsey
Colorcon
Merck
McKesson

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Drug Price Trends for TRI-LO-ESTARYLLA TABLET

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for TRI-LO-ESTARYLLA TABLET

Average Pharmacy Cost for TRI-LO-ESTARYLLA TABLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
TRI-LO-ESTARYLLA TABLET 70700-0120-84 0.20437 EACH 2019-10-16
TRI-LO-ESTARYLLA TABLET 70700-0120-85 0.20437 EACH 2019-09-18
TRI-LO-ESTARYLLA TABLET 00781-4062-15 0.20437 EACH 2019-09-18
TRI-LO-ESTARYLLA TABLET 70700-0120-85 0.23151 EACH 2019-08-21
TRI-LO-ESTARYLLA TABLET 00781-4062-15 0.23151 EACH 2019-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Colorcon
Harvard Business School
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.